Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study.
Ophthalmology
; 123(12): 2581-2587, 2016 12.
Article
en En
| MEDLINE
| ID: mdl-27707550
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Edema Macular
/
Inhibidores de la Angiogénesis
/
Retinopatía Diabética
/
Ranibizumab
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ophthalmology
Año:
2016
Tipo del documento:
Article